logo

For the Inventor, By the Inventor

Ramat-Hasharon, Israel

Michael Naveh

This inventor holds 7 USPTO granted patents. Top assignees: Renopharm Ltd., Vecta, Ltd.. Active years: 2007-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Naveh. Retrieved from https://idiyas.com/inventor/michael-naveh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7

Average Co-Inventor Count = 3.0

ph-index = 6

Forward Citations = 76(Granted Patents)


Company Filing History:

goldMedal6 out of 7 
 
Renopharm Ltd.
 patents
silverMedal1 out of 8 
 
Vecta, Ltd.
 patents

Years Active: 2007-2015

Loading Chart...
7 patents (USPTO):Explore Patents
1. 9132082 - Compositions and methods for inhibiting gastric acid secretion (2015-09-15),
2. 7968575 - Nitric oxide donors and uses thereof (2011-06-28),
3. 7579477 - Thiazole-based nitric oxide donors having alkyl substituent(s) and uses thereof (2009-08-25),
4. 7498445 - Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof (2009-03-03),
5. 7368577 - Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof (2008-05-06),
6. 7332513 - Thiazole-based nitric oxide donors having acyl substituent(s) and uses thereof (2008-02-19),
7. 7189750 - Thiazole-based nitric oxide donors having at least two thiazole moieties and uses thereof (2007-03-13),

Title: The Innovative Contributions of Michael Naveh

Introduction

Michael Naveh is a notable inventor based in Ramat-Hasharon, Israel. He holds a total of seven patents, showcasing his significant contributions to the field of medical innovations. His work primarily focuses on developing novel compositions and methods that address various medical conditions.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Compositions and methods for inhibiting gastric acid secretion." This invention relates to novel oral compositions that include an irreversible gastric H/KATPase proton pump inhibitor (PPI) as a gastric acid secretion inhibitor. The compositions also incorporate one or more small carboxylic acid molecules that act as parietal cell activators in the gastric lumen. Remarkably, these compositions enhance the anti-acid activity of the PPI in the stomach, providing a method to reduce gastric acid secretion in mammals.

Another significant patent by Naveh is "Nitric oxide donors and uses thereof." This invention discloses novel NO-donating compounds designed to release nitric oxide while forming a naturally occurring metabolite residue. This design prevents or decreases the development of tolerance to the compounds upon repetitive administration. The patent also includes methods for preparing these NO-donating compounds, as well as pharmaceutical compositions and medical devices that utilize them in treating various medical conditions.

Career Highlights

Michael Naveh has worked with several companies throughout his career, including Renopharm Ltd. and Vecta Ltd. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.

Collaborations

Naveh has collaborated with notable professionals in his field, including Peter Assaf and Elham Gazaleen-Mariee. These collaborations have likely enriched his research and development efforts.

Conclusion

Michael Naveh's contributions to medical innovation through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to impact the development of effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…